- UHRA Home
- Browsing by Author
Browsing by Author "Paciorek, Przemysław"
Now showing items 1-2 of 2
-
Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction : A prospective, observational, single-centre study
Adamski, Piotr; Sikora, Joanna; Laskowska, Ewa; Buszko, Katarzyna; Ostrowska, Małgorzata; Umińska, Julia M; Sikora, Adam; Skibińska, Natalia; Sobczak, Przemysław; Adamska, Urszula; Rość, Danuta; Kubica, Aldona; Paciorek, Przemysław; Marszałł, Michał P; Navarese, Eliano P; Gorog, Diana A; Kubica, Jacek (2017-10-12)BACKGROUND: Data from available studies suggest that the presence of ST-elevation myocardial infarction (STEMI) may be associated with delayed and attenuated ticagrelor bioavailability and effect compared with non-ST-elevation ... -
Metabolism of ticagrelor in patients with acute coronary syndromes.
Adamski, Piotr; Buszko, Katarzyna; Sikora, Joanna; Niezgoda, Piotr; Barańska, Malwina; Ostrowska, Małgorzata; Paciorek, Przemysław; Navarese, Eliano P; Gorog, Diana; Kubica, Jacek (2018-09-06)Ticagrelor is a state-of-the-art antiplatelet agent used for the treatment of patients with acute coronary syndromes (ACS). Unlike remaining oral P2Y12 receptor inhibitors ticagrelor does not require metabolic activation ...